FindTrial
Sign In

Use of a modified reverse sural neurofasciocutaneous flap to extend the reconstruction range

Use of a modified reverse sural neurofasciocutaneous flap to extend the reconstruction range

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046323
Enrollment
Unknown
Registered
2021-05-14
Start date
2010-07-01
Completion date
Unknown
Last updated
2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Soft tissue defect of lower extremity

Interventions

Modified retrograde sural neurofasciocutaneous flap was obtained:Nil
traditional sural neurofasciocutaneous flap was obtained:Nil

Sponsors

The First Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 65 Years

Inclusion criteria

Inclusion criteria: Large area of soft tissue defect, bone exposure, tendon exposure, can not be repaired by skin grafting.

Exclusion criteria

Exclusion criteria: Subjects related: Diabetes, vascular diseases, immune system diseases; Related to pathological changes: Wound infection, osteonecrosis, severe edema of lower limbs, and no flap replantation

Design outcomes

Primary

MeasureTime frame
Perforator position of flap;Position of the rotation point;One stage survival rate of skin flap;—

Countries

China

Contacts

Public ContactHuang Xin

The First Affiliated Hospital, Zhejiang University School of Medicine

xinh8@zju.edu.cn+86 15968107667

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026